Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-006114-14Phase 4Unknown
Phase 4, randomised, double-blind trial in Hypogonadism and type 2 diabetes mellitus (T2DM) comparing Nebido add-on with Placebo add-on (2 arms). Primary endpoints: HbA1c and fasting plasma glucose. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-006114-14.